PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Morgan, R.A.* ; Chinnasamy, N.* ; Abate-Daga, D.* ; Gros, A.* ; Robbins, P.F.* ; Zheng, Z.L.* ; Dudley, M.E.* ; Feldman, S.A.* ; Yang, J.C.* ; Sherry, R.M.* ; Phan, G.Q.* ; Hughes, M.S.* ; Kammula, U.S.* ; Miller, A.D.* ; Hessman, C.J.* ; Stewart, A.A.* ; Restifo, N.P.* ; Quezado, M.M.* ; Alimchandani, M.* ; Rosenberg, A.Z.* ; Nath, A.* ; Wang, T.G.* ; Bielekova, B.* ; Wuest, S.C.* ; Akula, N.* ; McMahon, F.J.* ; Wilde, S. ; Mosetter, B. ; Schendel, D.J. ; Laurencot, C.M.* ; Rosenberg, S.A.*

Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

J. Immunother. 36, 133-151 (2013)
DOI PMC
Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Nine cancer patients were treated with adoptive cell therapy using autologous anti-MAGE-A3 T-cell receptors (TCR)engineered T cells. Five patients experienced clinical regression of their cancers including 2 on-going responders. Beginning 1-2 days postinfusion, 3 patients (#'s 5, 7, and 8) experienced mental status changes, and 2 patients (5 and 8) lapsed into comas and subsequently died. Magnetic resonance imagining analysis of patients 5 and 8 demonstrated periventricular leukomalacia, and examination of their brains at autopsy revealed necrotizing leukoence-phalopathy with extensive white matter defects associated with infiltration of CD3(+) /CD8(+) T cells. Patient 7, developed Parkinson- like symptoms, which resolved over 4 weeks and fully recovered. Immunohistochemical staining of patient and normal brain samples demonstrated rare positively staining neurons with an antibody that recognizes multiple MAGE-A family members. The TCR used in this study recognized epitopes in MAGE-A3/A9/A12. Molecular assays of human brain samples using real-time quantitative-polymerase chain reaction, Nanostring quantitation, and deep-sequencing indicated that MAGE-A12 was expressed in human brain (and possibly MAGE-A1, MAGE-A8, and MAGEA9). This previously unrecognized expression of MAGE-A12 in human brain was possibly the initiating event of a TCR-mediated inflammatory response that resulted in neuronal cell destruction and raises caution for clinical applications targeting MAGE-A family members with highly active immunotherapies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.463
0.834
544
563
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cancer-testes Antigen ; Immunotherapy ; Tcr ; Gene Therapy; Inflammatory Demyelinating Polyneuropathy ; Adoptive Cell Therapy ; Cd8(+) T-cells ; Mage-a Family ; Metastatic Melanoma ; Multiple-sclerosis ; Cancer/testis Antigens ; Malignant-melanoma ; Prostate-cancer ; Clinical-trial
Sprache englisch
Veröffentlichungsjahr 2013
HGF-Berichtsjahr 2013
ISSN (print) / ISBN 1524-9557
e-ISSN 1537-4513
Zeitschrift Journal of Immunotherapy
Quellenangaben Band: 36, Heft: 2, Seiten: 133-151 Artikelnummer: , Supplement: ,
Verlag Lippincott Williams & Wilkins
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Molecular Immunology (IMI)
POF Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-501700-002
G-501700-001
G-501790-001
PubMed ID 23377668
DOI 10.1097/CJI.0b013e3182829903
WOS ID WOS:000314916000007
Scopus ID 84873991752
Erfassungsdatum 2013-03-15
[➜Korrektur melden]